相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies
Jing-dong Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)
CDH1 (E-cadherin) expression independently affects clinical outcome in acute myeloid leukemia with normal cytogenetics
Ting-juan Zhang et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2017)
Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia
Jing-Dong Zhou et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory
Eli Raveh et al.
MOLECULAR CANCER (2015)
High expression of long non-coding RNA H19 is required for efficient tumorigenesis induced by Bcr-Abl oncogene
Guijie Guo et al.
FEBS LETTERS (2014)
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
David Grimwade et al.
BLOOD (2010)
Aberrant epigenetic modifications in the CTCF binding domain of the IGF2/H19 gene in prostate cancer compared with benign prostate hyperplasia
Agnieszka Paradowska et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2009)
Hypomethylated and hypermethylated profiles of H19DMR are associated with the aberrant imprinting of IGF2 and H19 in human hepatocellular carcinoma
Jing Wu et al.
GENOMICS (2008)
Loss of H19 imprinting in adult T-cell leukaemia/lymphoma
Seisho Takeuchi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Regulation of the H19 imprinting gene expression in human nasopharyngeal carcinoma by methylation
A Ng et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Loss of imprinting of IGF2 and H19 in osteosarcoma is accompanied by reciprocal methylation changes of a CTCF-binding site
GA Ulaner et al.
HUMAN MOLECULAR GENETICS (2003)
The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage
AH Elmaagacli et al.
ANNALS OF HEMATOLOGY (2000)